Zevra Therapeutics, Inc. announced that The Board accepted the resignation of Richard W. Pascoe from his role as CEO, effective June 1, 2023 and The Board intends to appoint an interim-Chief Executive Officer and will immediately initiate a search to identify both a new Chief Executive Officer.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.745 USD | +0.96% | +3.26% | -27.56% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.56% | 197M | |
+18.74% | 78.7B | |
+14.09% | 9.26B | |
-15.14% | 4.92B | |
+48.58% | 4.66B | |
+15.70% | 4.27B | |
+18.52% | 2.44B | |
-25.55% | 2.22B | |
+15.73% | 2.15B | |
-40.52% | 1.89B |
- Stock Market
- Equities
- ZVRA Stock
- News Zevra Therapeutics, Inc.
- Zevra Therapeutics, Inc. Announces Change of CEO, Effective June 1, 2023